160 related articles for article (PubMed ID: 20459791)
1. Interference with activator protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation-sensitivity in breast cancer cells.
Thewes V; Orso F; Jäger R; Eckert D; Schäfer S; Kirfel G; Garbe S; Taverna D; Schorle H
BMC Cancer; 2010 May; 10():192. PubMed ID: 20459791
[TBL] [Abstract][Full Text] [Related]
2. Alternative TFAP2A isoforms have distinct activities in breast cancer.
Berlato C; Chan KV; Price AM; Canosa M; Scibetta AG; Hurst HC
Breast Cancer Res; 2011 Mar; 13(2):R23. PubMed ID: 21375726
[TBL] [Abstract][Full Text] [Related]
3. Ku proteins interact with activator protein-2 transcription factors and contribute to ERBB2 overexpression in breast cancer cell lines.
Nolens G; Pignon JC; Koopmansch B; Elmoualij B; Zorzi W; De Pauw E; Winkler R
Breast Cancer Res; 2009; 11(6):R83. PubMed ID: 19906305
[TBL] [Abstract][Full Text] [Related]
4. Identification of target genes of transcription factor activator protein 2 gamma in breast cancer cells.
Ailan H; Xiangwen X; Daolong R; Lu G; Xiaofeng D; Xi Q; Xingwang H; Rushi L; Jian Z; Shuanglin X
BMC Cancer; 2009 Aug; 9():279. PubMed ID: 19671168
[TBL] [Abstract][Full Text] [Related]
5. Functional genomics of AP-2α and AP-2γ in cancers: in silico study.
Kołat D; Kałuzińska Ż; Orzechowska M; Bednarek AK; Płuciennik E
BMC Med Genomics; 2020 Nov; 13(1):174. PubMed ID: 33213447
[TBL] [Abstract][Full Text] [Related]
6. A
Wu VT; Kiriazov B; Koch KE; Gu VW; Beck AC; Borcherding N; Li T; Addo P; Wehrspan ZJ; Zhang W; Braun TA; Brown BJ; Band V; Band H; Kulak MV; Weigel RJ
Mol Cancer Res; 2020 Jan; 18(1):46-56. PubMed ID: 31619506
[TBL] [Abstract][Full Text] [Related]
7. Activator protein-2 in carcinogenesis with a special reference to breast cancer--a mini review.
Pellikainen JM; Kosma VM
Int J Cancer; 2007 May; 120(10):2061-7. PubMed ID: 17330235
[TBL] [Abstract][Full Text] [Related]
8. AP-2alpha and AP-2gamma regulate tumor progression via specific genetic programs.
Orso F; Penna E; Cimino D; Astanina E; Maione F; Valdembri D; Giraudo E; Serini G; Sismondi P; De Bortoli M; Taverna D
FASEB J; 2008 Aug; 22(8):2702-14. PubMed ID: 18443366
[TBL] [Abstract][Full Text] [Related]
9. Transcription factor AP-2gamma stimulates proliferation and apoptosis and impairs differentiation in a transgenic model.
Jäger R; Werling U; Rimpf S; Jacob A; Schorle H
Mol Cancer Res; 2003 Oct; 1(12):921-9. PubMed ID: 14573793
[TBL] [Abstract][Full Text] [Related]
10. AP-2alpha and AP-2gamma are transcriptional targets of p53 in human breast carcinoma cells.
Li H; Watts GS; Oshiro MM; Futscher BW; Domann FE
Oncogene; 2006 Aug; 25(39):5405-15. PubMed ID: 16636674
[TBL] [Abstract][Full Text] [Related]
11. The AP-2alpha transcription factor regulates tumor cell migration and apoptosis.
Orso F; Fassetta M; Penna E; Solero A; De Filippo K; Sismondi P; De Bortoli M; Taverna D
Adv Exp Med Biol; 2007; 604():87-95. PubMed ID: 17695722
[TBL] [Abstract][Full Text] [Related]
12. AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase.
Orso F; Jäger R; Calogero RA; Schorle H; Sismondi P; De Bortoli M; Taverna D
BMC Biol; 2009 May; 7():25. PubMed ID: 19463168
[TBL] [Abstract][Full Text] [Related]
13. Synergistic silencing by promoter methylation and reduced AP-2α transactivation of the proapoptotic HRK gene confers apoptosis resistance and enhanced tumor growth.
Xu M; Chen X; Chen N; Nie L; Li X; Li Q; Zeng H; Zhou Q
Am J Pathol; 2013 Jan; 182(1):84-95. PubMed ID: 23159945
[TBL] [Abstract][Full Text] [Related]
14. Dual role of AP-2gamma in ErbB-2-induced mammary tumorigenesis.
Jäger R; Friedrichs N; Heim I; Büttner R; Schorle H
Breast Cancer Res Treat; 2005 Apr; 90(3):273-80. PubMed ID: 15830141
[TBL] [Abstract][Full Text] [Related]
15. Regulation of KiSS-1 metastasis suppressor gene expression in breast cancer cells by direct interaction of transcription factors activator protein-2alpha and specificity protein-1.
Mitchell DC; Abdelrahim M; Weng J; Stafford LJ; Safe S; Bar-Eli M; Liu M
J Biol Chem; 2006 Jan; 281(1):51-8. PubMed ID: 16260418
[TBL] [Abstract][Full Text] [Related]
16. Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.
Aka JA; Calvo EL; Lin SX
Mol Cell Endocrinol; 2017 Jan; 439():175-186. PubMed ID: 27544780
[TBL] [Abstract][Full Text] [Related]
17. The combined immunodetection of AP-2alpha and YY1 transcription factors is associated with ERBB2 gene overexpression in primary breast tumors.
Allouche A; Nolens G; Tancredi A; Delacroix L; Mardaga J; Fridman V; Winkler R; Boniver J; Delvenne P; Begon DY
Breast Cancer Res; 2008; 10(1):R9. PubMed ID: 18218085
[TBL] [Abstract][Full Text] [Related]
18. AP-2α reverses vincristine-induced multidrug resistance of SGC7901 gastric cancer cells by inhibiting the Notch pathway.
Lian W; Zhang L; Yang L; Chen W
Apoptosis; 2017 Jul; 22(7):933-941. PubMed ID: 28439677
[TBL] [Abstract][Full Text] [Related]
19. Re-expression of SPR1 in breast cancer cells by phorbol 12-myristate 13-acetate (PMA) or UV irradiation is mediated by the AP-1 binding site in the SPR1 promoter.
Anisowicz A; Sotiropoulou G; Sager R
Mol Med; 1999 Aug; 5(8):526-41. PubMed ID: 10501656
[TBL] [Abstract][Full Text] [Related]
20. [Dual role of transcription factor AP-2 in carcinogenesis].
Liang S; Deng H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 39(4):430-5. PubMed ID: 20731046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
